In the last trading session, 4.19 million shares of the Teladoc Health Inc (NYSE:TDOC) were traded, and its beta was 1.72. Most recently the company’s share price was $8.64, and it changed around -$0.18 or -2.04% from the last close, which brings the market valuation of the company to $1.50B. TDOC currently trades at a discount to its 52-week high of $15.43, offering almost -78.59% off that amount. The share price’s 52-week low was $6.76, which indicates that the current value has risen by an impressive 21.76% since then. We note from Teladoc Health Inc’s average daily trading volume that its 10-day average is 5.57 million shares, with the 3-month average coming to 7.64 million.
Teladoc Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.52. If we narrow it down even further, the data shows that 0 out of 25 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 19 recommended TDOC as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Teladoc Health Inc is expected to report earnings per share of -0.36 for the current quarter.
Teladoc Health Inc (NYSE:TDOC) trade information
Instantly TDOC has showed a red trend with a performance of -2.04% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 8.88 on recent trading dayincreased the stock’s daily price by 2.7%. The company’s shares are currently down -4.95% year-to-date, but still up 2.98% over the last five days. On the other hand, Teladoc Health Inc (NYSE:TDOC) is -24.14% down in the 30-day period. We can see from the shorts that 25.02 million shares have been sold at a short interest cover period of 2.22 day(s).
The consensus price target as assigned by Wall Street analysts is $11, which translates to bulls needing to increase their stock price by 21.45% from its current value. Analyst projections state that TDOC is forecast to be at a low of $9 and a high of $13.
Teladoc Health Inc (TDOC) estimates and forecasts
The year-over-year growth rate is expected to be -1.93%, down from the previous year.
Consensus estimates provided by 22 financial analysts predict the company will bring in an average of 619.38M in revenue for the current quarter. 22 analysts expect Teladoc Health Inc to make 624.93M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 646.13M and 642.44M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -4.14%. Forecasts for the next quarter put sales growth at -2.73%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -33.66%. Teladoc Health Inc earnings are expected to increase by 83.83% in 2025, but the outlook is positive 48.98% per year for the next five years.
TDOC Dividends
Teladoc Health Inc’s next quarterly earnings report is expected to be released on 2025-Feb-25.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.84% of Teladoc Health Inc shares, and 75.90% of them are in the hands of institutional investors. The stock currently has a share float of 76.54%. Teladoc Health Inc stock is held by 537.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 12.6952% of the shares, which is about 21.61 million shares worth $211.35 million.
VANGUARD GROUP INC, with 10.2643% or 17.22 million shares worth $168.38 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 5.25 shares worth $45.37 million, making up 3.02% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 4.64 shares worth around $40.11 million, which represents about 2.67% of the total shares outstanding.
